Scribe Therapeutics, Inc.
SCTX
Transaktioner
51
Köp
51
Sälj
0
Nettoinsynsflöde
255.2 mn USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
Ingen prisdata ännuIngen prisserie har matchats mot detta bolag ännu.
Avkastning efter transaktion
Median-% efter transaktionsdatumKursserien för detta bolag rör sig i tick som är stora i förhållande till aktiekursen, så procentuell avkastning skulle domineras av avrundningsbrus snarare än av verkliga kursrörelser. Avkastningsstatistik visas därför inte.
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning–
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
51 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2026-07-28 | Aghazadeh Behzad | Director, 10% owner | Buy | 8 k | 18,25 | 144 k USD |
| 2026-07-28 | Aghazadeh Behzad | Director, 10% owner | Buy | 8 k | 18,25 | 144 k USD |
| 2026-07-28 | Aghazadeh Behzad | Director, 10% owner | Buy | 8 k | 18,25 | 144 k USD |
| 2026-07-28 | Aghazadeh Behzad | Director, 10% owner | Buy | 8 k | 18,25 | 144 k USD |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 2.1 mn | – | – |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 698 k | – | – |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 333 k | 15,00 | 5.0 mn USD |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 2.1 mn | – | – |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 698 k | – | – |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 333 k | 15,00 | 5.0 mn USD |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 2.1 mn | – | – |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 698 k | – | – |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 333 k | 15,00 | 5.0 mn USD |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 2.1 mn | – | – |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 698 k | – | – |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 333 k | 15,00 | 5.0 mn USD |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 2.1 mn | – | – |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 698 k | – | – |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 333 k | 15,00 | 5.0 mn USD |
| 2026-07-27 | Doudna Jennifer A | 10% owner | Buy | 13 k | – | – |
| 2026-07-27 | GORDON CARL L | Director | Buy | 349 k | – | – |
| 2026-07-27 | GORDON CARL L | Director | Buy | 1.0 mn | 15,00 | 15.0 mn USD |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 2.1 mn | – | – |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 698 k | – | – |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 333 k | 15,00 | 5.0 mn USD |
| 2026-07-27 | ORBIMED ADVISORS LLC | Director | Buy | 349 k | – | – |
| 2026-07-27 | ORBIMED ADVISORS LLC | Director | Buy | 1.0 mn | 15,00 | 15.0 mn USD |
| 2026-07-27 | ORBIMED ADVISORS LLC | Director | Buy | 349 k | – | – |
| 2026-07-27 | ORBIMED ADVISORS LLC | Director | Buy | 1.0 mn | 15,00 | 15.0 mn USD |
| 2026-07-27 | ORBIMED ADVISORS LLC | Director | Buy | 349 k | – | – |
| 2026-07-27 | ORBIMED ADVISORS LLC | Director | Buy | 1.0 mn | 15,00 | 15.0 mn USD |
| 2026-07-27 | GORDON CARL L | Director | Buy | 349 k | – | – |
| 2026-07-27 | GORDON CARL L | Director | Buy | 1.0 mn | 15,00 | 15.0 mn USD |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 2.1 mn | – | – |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 698 k | – | – |
| 2026-07-27 | AH Bio Fund II, L.P. | 10% owner | Buy | 333 k | 15,00 | 5.0 mn USD |
| 2026-07-27 | Doudna Jennifer A | 10% owner | Buy | 13 k | – | – |
| 2026-07-24 | Aghazadeh Behzad | Director, 10% owner | Buy | 2.3 mn | 15,00 | 35.0 mn USD |
| 2026-07-24 | Aghazadeh Behzad | Director, 10% owner | Buy | 50 k | 22,31 | 1.1 mn USD |
| 2026-07-24 | Aghazadeh Behzad | Director, 10% owner | Buy | 2.3 mn | 15,00 | 35.0 mn USD |
| 2026-07-24 | Aghazadeh Behzad | Director, 10% owner | Buy | 50 k | 22,31 | 1.1 mn USD |
| 2026-07-24 | Aghazadeh Behzad | Director, 10% owner | Buy | 2.3 mn | 15,00 | 35.0 mn USD |
| 2026-07-24 | Aghazadeh Behzad | Director, 10% owner | Buy | 50 k | 22,31 | 1.1 mn USD |
| 2026-07-24 | Aghazadeh Behzad | Director, 10% owner | Buy | 2.3 mn | 15,00 | 35.0 mn USD |
| 2026-07-24 | Aghazadeh Behzad | Director, 10% owner | Buy | 50 k | 22,31 | 1.1 mn USD |
| 2026-07-23 | Lucas Svetlana | Chief Business Officer | Buy | 3 k | 15,00 | 45 k USD |
| 2026-07-23 | Parrot David | Chief Financial Officer | Buy | 1 k | 15,00 | 20 k USD |
| 2026-07-23 | Parrot David | Chief Financial Officer | Buy | 1 k | 15,00 | 20 k USD |
| 2026-07-23 | Lucas Svetlana | Chief Business Officer | Buy | 3 k | 15,00 | 45 k USD |
| 2026-07-23 | Parrot David | Chief Financial Officer | Buy | 1 k | 15,00 | 20 k USD |
| 2026-07-23 | Parrot David | Chief Financial Officer | Buy | 1 k | 15,00 | 20 k USD |